FHIR © HL7.org  |  Server Home  |  FHIR Server FHIR Server 3.7.22-SNAPSHOT  |  FHIR Version n/a  User: [n/a]

770717002: Avatrombopag (substance)


Status: current, Not sufficiently defined by necessary conditions definition status (core metadata concept). Date: 31-Jan 2019. Module: SNOMED CT core

Descriptions:

Id Description Lang Type Status Case? Module
3702219012 Avatrombopag en Synonym (core metadata concept) Active Entire term case insensitive (core metadata concept) SNOMED CT core
3702220018 Avatrombopag (substance) en Fully specified name Active Entire term case insensitive (core metadata concept) SNOMED CT core
5520461000241115 avatrombopag fr Synonym (core metadata concept) Active Entire term case insensitive (core metadata concept) SNOMED CT Switzerland NRC maintained Module


0 descendants.

Expanded Value Set


Outbound Relationships Type Target Active Characteristic Refinability Group Values
Avatrombopag Is a Thiophene true Inferred relationship Some
Avatrombopag This attribute specifies the behavior that a substance will exhibit or participate in, given the appropriate context. Thrombopoietin receptor agonist (disposition) true Inferred relationship Some
Avatrombopag Is a Receptor agonist false Inferred relationship Some
Avatrombopag Is a Thrombopoietin receptor agonist true Inferred relationship Some

Inbound Relationships Type Active Source Characteristic Refinability Group
Avatrombopag-containing product The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. True Avatrombopag Inferred relationship Some 1
Product containing avatrombopag in oral dose form (medicinal product form) The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. True Avatrombopag Inferred relationship Some 1
Product containing only avatrombopag (medicinal product) The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. True Avatrombopag Inferred relationship Some 1
Product containing only avatrombopag in oral dose form (medicinal product form) The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. True Avatrombopag Inferred relationship Some 1
Product containing precisely avatrombopag (as avatrombopag maleate) 20 milligram/1 each conventional release oral tablet (clinical drug) This attribute represents an ingredient that is the part of the active ingredient that the strength of a given product is based upon. True Avatrombopag Inferred relationship Some 1
Avatrombopag maleate (substance) This attribute indicates that the concept is a structural modification of another concept, and that the substance's intrinsic physicochemical properties remain unchanged. True Avatrombopag Inferred relationship Some

This concept is not in any reference sets

Back to Start